TrialCPT: pharmacometrics & systems pharmacology2022

Population pharmacokinetics of mobocertinib in healthy volunteers and patients with non-small cell lung cancer.

Neeraj Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.